Your Search Results

Abstracts - Part 2

11 Dec 2025 – From GulfPCR-GIM 2025

This session compiles recent clinical abstracts addressing diverse topics in interventional cardiology. Highlights include the HYBRID-CTO approach from a prospective case series, the cardiovascular impact of empagliflozin in type 2 diabetes, off-label use of intravascular lithotripsy for resistant in-stent lesions, and experiences with non-hyperaemic pressure ratios...

Beyond the horizon - Shaping the future of cardiology through meaningful innovation in structural heart and coronary - LIVE Case

11 Dec 2025 – From GulfPCR-GIM 2025

This live case–based session explores how innovation is shaping structural heart and coronary interventions.

A real-time TAVI case in a degenerated aortic valve highlights pre-procedural imaging, sizing strategies, procedural decision-making, and post-procedural care.

The session also reviews ongoing and upcoming Myval THV trials, showing how new technologies impact...

Beyond the horizon - Shaping the future of cardiology through meaningful innovation in structural heart and coronary

Global momentum of Shockwave intravascular lithotripsy: evidence, experience and evolution

11 Dec 2025 – From GulfPCR-GIM 2025

This session examines the growing global experience in the treatment of calcified coronary lesions, bringing together updated clinical evidence and real-world practice.

Recent data are discussed alongside insights from high-volume operators to show how calcium modification strategies are evolving and being integrated into contemporary PCI workflows.

By combining...

Global momentum of Shockwave intravascular lithotripsy: evidence, experience and evolution

Vascular interventions for the invasive cardiologist

11 Dec 2025 – From GulfPCR-GIM 2025

This session delivers a comprehensive overview of recent guideline changes in peripheral vascular disease and shares expert cardiologist experiences in various vascular interventions through case-based discussions. It also focuses on recognizing and managing peripheral vascular complications effectively to optimize patient outcomes.

Vascular interventions for the invasive cardiologist

Challenging STEMI scenarios - Part 1

11 Dec 2025 – From GulfPCR-GIM 2025

This session addresses challenging STEMI scenarios with a focus on atypical presentations, complex complications, and advanced management strategies. Through diverse case discussions, it highlights approaches to overcome procedural difficulties, manage large thrombus burdens, and avoid clinical pitfalls in acute STEMI care.

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Author

Alessandro Sticchi

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...